Augmented risk of ischemic stroke in hypertrophic cardiomyopathy patients without documented atrial fibrillation
You-Jung Choi1,2, Bongseong Kim3, Tae-Min Rhee2,4
1Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital & Korea University College of Medicine, Seoul, Korea.
Insights
Hypertrophic cardiomyopathy (HCM) patients without atrial fibrillation (AF) face a higher risk of ischemic stroke (IS). This risk is particularly elevated in older individuals and those with heart failure, highlighting a critical need for proactive management.
Area of Science:
- Cardiology
- Neurology
- Public Health
Background:
- Atrial fibrillation (AF) is a known risk factor for ischemic stroke (IS) in hypertrophic cardiomyopathy (HCM).
- The risk of IS in HCM patients without documented AF is less understood.
- This study addresses the underrecognized risk of IS in HCM patients without AF.
Purpose of the Study:
- To investigate the incidence and risk factors of IS in HCM patients without documented AF.
- To compare the risk of IS in HCM patients without AF to a matched control group.
- To identify specific subgroups within the HCM population at higher risk for IS.
Main Methods:
- Nationwide population-based cohort study using the Korean National Health Insurance database.
- Included 8,328 HCM patients without documented AF and 16,656 matched non-HCM controls (2010-2016).
- Propensity score matching was used to control for confounding factors; primary outcome was incident IS.
Main Results:
- The incidence of IS was significantly higher in the HCM group (3.9%) compared to controls (2.7%).
- Overall IS incidence was 0.72/100 person-years in HCM patients versus 0.44/100 person-years in controls (HR 1.64).
- Age ≥ 65 years (aHR 2.74) and chronic heart failure (aHR 1.75) were independent risk factors for IS in HCM patients without AF.
Conclusions:
- HCM patients without documented AF have an elevated risk of IS.
- Older age (≥ 65 years) and co-existing chronic heart failure significantly increase IS risk in this population.
- These findings emphasize the importance of risk stratification and management for IS in HCM patients, even in the absence of AF.
Abstract:
Although atrial fibrillation (AF) is a well-established risk factor for ischemic stroke (IS) in hypertrophic cardiomyopathy (HCM), the risk of IS in HCM patients without documented AF is less recognized. This nationwide population-based cohort study using Korean National Health Insurance database included 8,328 HCM patients without documented AF and 1:2 propensity score-matched 16,656 non-HCM controls between 2010 and 2016. The primary outcome was an incident IS. During a mean follow-up of 6.1 years, IS occurred in 328/8,328 (3.9%) patients with HCM and 443/16,656 (2.7%) controls. The overall incidence of IS was 0.72/100 person-years in the HCM group, which was significantly higher than that in the control group (0.44/100 person-years) (HR 1.64; 95% CI 1.424-1.895; P < 0.001). The overall incidence of IS was 1.36/100 person-years in HCM patients aged ≥ 65 and 2.32/100 person-years years in those with heart failure, respectively. In the HCM group, age ≥ 65 years (adjusted HR 2.74; 95% CI 2.156-3.486; P < 0.001) and chronic heart failure (adjusted HR 1.75; 95% CI 1.101-2.745; P = 0.018) were independent risk factors for IS. HCM patients without documented AF are at a greater risk of IS, especially in those 65 years of age or older or those with chronic heart failure.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy


